创新药行业周报:创新药收入快速增长 开启盈利驱动新周期

湘财证券股份有...
08 May

核心要点:创新药行业开启盈利驱动新周期创新药商业化持续放量及海外授权交易推动营业收入快速增长,统计A、H 两地40 家Biotech 公司,2024 年实现营业收入834.8 亿元,同比增长43.6%,行业保持快速增长。2024 年21 家Biotech 公司营业收入上升至5亿元以上,数量占比达到53%。17 家公司营业收入增速超过50%,头部公司百济神州受益于美国市场持续放量,2024 年营业...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10